Variant report
Variant | nsv571826 |
---|---|
Chromosome Location | chr16:32001824-32597694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3935)
- CpG islands (count:3847)
- Chromatin interactive region (count:1)
- LncRNA region (count:21)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr16:32295698-32295892 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr16:32345726-32345816 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr16:32131861-32132041 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr16:32547652-32548159 | K562 | blood: | n/a | n/a |
5 | ARID3A | chr16:32590243-32590613 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr16:32583782-32583972 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr16:32550785-32551178 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr16:32526924-32527721 | K562 | blood: | n/a | n/a |
9 | ATF1 | chr16:32515726-32516011 | K562 | blood: | n/a | n/a |
10 | ATF1 | chr16:32559923-32560294 | K562 | blood: | n/a | n/a |
11 | ATF1 | chr16:32194699-32194908 | K562 | blood: | n/a | n/a |
12 | ATF1 | chr16:32549843-32550009 | K562 | blood: | n/a | n/a |
13 | ATF1 | chr16:32558594-32558903 | K562 | blood: | n/a | n/a |
14 | ATF1 | chr16:32568174-32568349 | K562 | blood: | n/a | n/a |
15 | ATF1 | chr16:32547497-32547620 | K562 | blood: | n/a | n/a |
16 | ATF1 | chr16:32363593-32363793 | K562 | blood: | n/a | n/a |
17 | ATF1 | chr16:32521319-32521519 | K562 | blood: | n/a | n/a |
18 | BACH1 | chr16:32531668-32531907 | K562 | blood: | n/a | n/a |
19 | BACH1 | chr16:32590237-32590618 | K562 | blood: | n/a | n/a |
20 | BACH1 | chr16:32553830-32554374 | K562 | blood: | n/a | n/a |
21 | BATF | chr16:32366962-32367454 | GM12878 | blood: | n/a | chr16:32367243-32367254 |
22 | BATF | chr16:32144482-32144672 | GM12878 | blood: | n/a | n/a |
23 | BATF | chr16:32102790-32103063 | GM12878 | blood: | n/a | n/a |
24 | BATF | chr16:32373029-32373235 | GM12878 | blood: | n/a | n/a |
25 | BATF | chr16:32059238-32059578 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr16:32101090-32101595 | GM12878 | blood: | n/a | chr16:32101437-32101448 |
27 | BATF | chr16:32148154-32148425 | GM12878 | blood: | n/a | n/a |
28 | BATF | chr16:32451259-32451478 | GM12878 | blood: | n/a | n/a |
29 | BATF | chr16:32361068-32361342 | GM12878 | blood: | n/a | n/a |
30 | BATF | chr16:32059227-32059446 | GM12878 | blood: | n/a | n/a |
31 | BATF | chr16:32368414-32368848 | GM12878 | blood: | n/a | n/a |
32 | BATF | chr16:32368458-32368823 | GM12878 | blood: | n/a | n/a |
33 | BATF | chr16:32139079-32139319 | GM12878 | blood: | n/a | n/a |
34 | BATF | chr16:32050371-32050791 | GM12878 | blood: | n/a | n/a |
35 | BATF | chr16:32099023-32099501 | GM12878 | blood: | n/a | n/a |
36 | BATF | chr16:32007628-32007992 | GM12878 | blood: | n/a | n/a |
37 | BATF | chr16:32098574-32098849 | GM12878 | blood: | n/a | n/a |
38 | BATF | chr16:32102770-32103216 | GM12878 | blood: | n/a | n/a |
39 | BATF | chr16:32144456-32144674 | GM12878 | blood: | n/a | n/a |
40 | BATF | chr16:32335083-32335294 | GM12878 | blood: | n/a | n/a |
41 | BATF | chr16:32150053-32150293 | GM12878 | blood: | n/a | n/a |
42 | BATF | chr16:32333643-32333817 | GM12878 | blood: | n/a | n/a |
43 | BATF | chr16:32133941-32134130 | GM12878 | blood: | n/a | n/a |
44 | BATF | chr16:32335047-32335307 | GM12878 | blood: | n/a | n/a |
45 | BATF | chr16:32099644-32100206 | GM12878 | blood: | n/a | n/a |
46 | BATF | chr16:32435147-32435451 | GM12878 | blood: | n/a | n/a |
47 | BATF | chr16:32101215-32101624 | GM12878 | blood: | n/a | chr16:32101437-32101448 |
48 | BATF | chr16:32099142-32100510 | GM12878 | blood: | n/a | n/a |
49 | BATF | chr16:32140974-32141195 | GM12878 | blood: | n/a | n/a |
50 | BATF | chr16:32108268-32108476 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:32264389-32264439 | AG04450 | lung: | fetal |
2 | chr16:32288799-32288849 | HRE | kidney: | n/a |
3 | chr16:32486334-32486384 | IMR90 | lung: | fetal |
4 | chr16:32323497-32323547 | NB4 | blood: | n/a |
5 | chr16:32264389-32264439 | AG04450 | lung: | fetal |
6 | chr16:32288799-32288849 | HRE | kidney: | n/a |
7 | chr16:32486334-32486384 | IMR90 | lung: | fetal |
8 | chr16:32323497-32323547 | NB4 | blood: | n/a |
9 | chr16:32130303-32130353 | BE2_C | brain: | n/a |
10 | chr16:32201912-32201962 | HEK293 | kidney: | embryo |
11 | chr16:32095405-32095455 | HUVEC | blood vessel: | n/a |
12 | chr16:32290371-32290421 | MCF-7 | breast: | n/a |
13 | chr16:32265041-32265091 | GM12878 | blood: | n/a |
14 | chr16:32330265-32330315 | Caco-2 | colon: | n/a |
15 | chr16:32493059-32493109 | NHBE | bronchial: | n/a |
16 | chr16:32355981-32356031 | K562 | blood: | n/a |
17 | chr16:32487825-32487875 | SK-N-MC | brain: | n/a |
18 | chr16:32288799-32288849 | BE2_C | brain: | n/a |
19 | chr16:32360428-32360478 | Hela-S3 | cervix: | n/a |
20 | chr16:32130303-32130353 | GM19239 | blood: | n/a |
21 | chr16:32330302-32330352 | ProgFib | skin: | n/a |
22 | chr16:32473096-32473146 | HL-60 | blood: | n/a |
23 | chr16:32452502-32452552 | HEEpiC | esophagus: | n/a |
24 | chr16:32265747-32265797 | AG04450 | lung: | fetal |
25 | chr16:32289928-32289978 | HRPEpiC | eye: | n/a |
26 | chr16:32165153-32165203 | A549 | lung: | n/a |
27 | chr16:32288799-32288849 | K562 | blood: | n/a |
28 | chr16:32360428-32360478 | ovcar-3 | ovarian: | n/a |
29 | chr16:32165225-32165275 | RPTEC | kidney: | n/a |
30 | chr16:32489820-32489870 | GM12878 | blood: | n/a |
31 | chr16:32473096-32473146 | HCPEpiC | choroid plexus: | n/a |
32 | chr16:32037687-32037737 | SK-N-SH_RA | brain: | n/a |
33 | chr16:32127656-32127706 | GM12892 | blood: | n/a |
34 | chr16:32254800-32254850 | ECC-1 | luminal epithelium: | n/a |
35 | chr16:32363978-32364028 | IMR90 | lung: | fetal |
36 | chr16:32360428-32360478 | HPAEpiC | pulmonary alveolar: | n/a |
37 | chr16:32493059-32493109 | HCM | heart: | n/a |
38 | chr16:32289757-32289807 | SK-N-SH | brain: | n/a |
39 | chr16:32452725-32452775 | HepG2 | liver: | n/a |
40 | chr16:32452502-32452552 | HPAEpiC | pulmonary alveolar: | n/a |
41 | chr16:32096623-32096673 | HCT-116 | colon: | n/a |
42 | chr16:32486334-32486384 | HEEpiC | esophagus: | n/a |
43 | chr16:32252365-32252415 | SAEC | small airway: | n/a |
44 | chr16:32127656-32127706 | AG10803 | skin: | n/a |
45 | chr16:32252787-32252837 | HCT-116 | colon: | n/a |
46 | chr16:32360428-32360478 | RPTEC | kidney: | n/a |
47 | chr16:32264389-32264439 | AG09309 | skin: | n/a |
48 | chr16:32330302-32330352 | U87 | brain: | n/a |
49 | chr16:32323497-32323547 | A549 | lung: | n/a |
50 | chr16:32254800-32254850 | A549 | lung: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:106598214..106598843-chr16:32050606..32051126,2 | MCF-7 | breast: |
(count:21 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC133485.1.1-8 | chr16:32443002-32443139 | NONHSAT142015 |
2 | lnc-TP53TG3-4 | chr16:32274229-32274612 | ENSG00000260402.1 |
3 | lnc-TP53TG3-3 | chr16:32335100-32335382 | XLOC_011921 |
4 | lnc-AC133485.1.1-7 | chr16:32200583-32200802 | NONHSAT141994 |
5 | lnc-AC133485.1.1-8 | chr16:32416298-32416473 | NONHSAT142015 |
6 | lnc-TP53TG3-16 | chr16:32450390-32451887 | NONHSAT142016 |
7 | lnc-AC133485.1.1-8 | chr16:32437097-32437203 | NONHSAT142015 |
8 | lnc-TP53TG3-7 | chr16:32265674-32265743 | ENSG00000260575.1 |
9 | lnc-AC133485.1.1-8 | chr16:32442004-32442108 | NONHSAT142015 |
10 | lnc-AC133485.1.1-1 | chr16:32204071-32204851 | ENSG00000260847.1 |
11 | lnc-TP53TG3-7 | chr16:32261941-32262132 | ENSG00000260575.1 |
12 | lnc-AC133485.1.1-8 | chr16:32438035-32438184 | NONHSAT142015 |
13 | lnc-TP53TG3-4 | chr16:32275068-32275108 | ENSG00000260402.1 |
14 | lnc-AC133485.1.1-8 | chr16:32399456-32399634 | NONHSAT142015 |
15 | lnc-AC133485.1.1-1 | chr16:32199654-32199738 | ENSG00000260847.1 |
16 | lnc-TP53TG3-2 | chr16:32465933-32470079 | ENSG00000261541.1 |
17 | lnc-AC133485.1.1-8 | chr16:32403379-32403556 | NONHSAT142015 |
18 | lnc-TP53TG3-3 | chr16:32334099-32334218 | XLOC_011921 |
19 | lnc-TP53TG3-16 | chr16:32452294-32452480 | NONHSAT142016 |
20 | lnc-AC133485.1.1-8 | chr16:32402131-32402273 | NONHSAT142015 |
21 | lnc-AC133485.1.1-8 | chr16:32447309-32447521 | NONHSAT142015 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260540 | TF binding region |
ENSG00000261541 | TF binding region |
ENSG00000260402 | TF binding region |
ENSG00000260662 | TF binding region |
ENSG00000260575 | TF binding region |
ENSG00000259822 | TF binding region |
HERC2P4 | TF binding region |
ENSG00000223931 | TF binding region |
ENSG00000260628 | TF binding region |
ENSG00000260344 | TF binding region |
TP53TG3D | TF binding region |
ENSG00000260584 | TF binding region |
ENSG00000261127 | TF binding region |
IGHV1OR16-1 | TF binding region |
ENSG00000260649 | TF binding region |
IGHV3OR16-9 | TF binding region |
ACTR3BP3 | TF binding region |
ENSG00000260847 | TF binding region |
ENSG00000261727 | TF binding region |
ENSG00000260866 | TF binding region |
IGHV1OR16-3 | TF binding region |
ABCD1P3 | TF binding region |
PABPC1P13 | TF binding region |
ENSG00000260516 | TF binding region |
ENSG00000260540 | CpG island |
ENSG00000261541 | CpG island |
ENSG00000260402 | CpG island |
ENSG00000260662 | CpG island |
ENSG00000260575 | CpG island |
ENSG00000259822 | CpG island |
HERC2P4 | CpG island |
ENSG00000223931 | CpG island |
ENSG00000260628 | CpG island |
ENSG00000260344 | CpG island |
TP53TG3D | CpG island |
ENSG00000260584 | CpG island |
ENSG00000261127 | CpG island |
IGHV1OR16-1 | CpG island |
ENSG00000260649 | CpG island |
IGHV3OR16-9 | CpG island |
ACTR3BP3 | CpG island |
ENSG00000260847 | CpG island |
ENSG00000261727 | CpG island |
ENSG00000260866 | CpG island |
IGHV1OR16-3 | CpG island |
ABCD1P3 | CpG island |
PABPC1P13 | CpG island |
ENSG00000260516 | CpG island |
LBR | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2966274 | chr16:32001824-32001825 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs552937590 | chr16:32001842-32001843 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs577654022 | chr16:32001893-32001894 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs372613595 | chr16:32001914-32001915 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs190603504 | chr16:32001922-32001923 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs575329927 | chr16:32001924-32001925 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs11150658 | chr16:32001932-32001933 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs542680144 | chr16:32001954-32001955 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs58477186 | chr16:32002015-32002016 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs528842880 | chr16:32002147-32002148 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs374258420 | chr16:32002184-32002185 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs181072153 | chr16:32002475-32002476 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs530020395 | chr16:32002478-32002479 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs144361633 | chr16:32002480-32002481 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs567218206 | chr16:32002481-32002482 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs534638590 | chr16:32002488-32002489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546730675 | chr16:32002490-32002491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146120985 | chr16:32002501-32002502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538696018 | chr16:32002502-32002503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556767495 | chr16:32002524-32002525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371222915 | chr16:32002565-32002566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184380906 | chr16:32002585-32002586 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs140154921 | chr16:32002612-32002613 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs554647450 | chr16:32002620-32002621 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs573537962 | chr16:32002621-32002622 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs540573636 | chr16:32002638-32002639 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs565448136 | chr16:32002653-32002654 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs2939835 | chr16:32002671-32002672 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs562098476 | chr16:32002683-32002684 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs189738904 | chr16:32002806-32002807 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs143880642 | chr16:32002807-32002808 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs62055244 | chr16:32002821-32002822 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs62055245 | chr16:32002836-32002837 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs555244006 | chr16:32005374-32005375 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs533622225 | chr16:32005379-32005380 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs570427968 | chr16:32005455-32005456 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs538125611 | chr16:32005478-32005479 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs556427319 | chr16:32005499-32005500 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs568444564 | chr16:32005511-32005512 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs535652807 | chr16:32005533-32005534 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs553988385 | chr16:32005572-32005573 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs572409439 | chr16:32005598-32005599 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs539926119 | chr16:32005640-32005641 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs557840296 | chr16:32005655-32005656 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs187376283 | chr16:32005659-32005660 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs112618989 | chr16:32005680-32005681 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs574832382 | chr16:32005815-32005816 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs146081593 | chr16:32005816-32005817 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs542035948 | chr16:32005826-32005827 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs560302193 | chr16:32005866-32005867 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Mental retardation | 19951919 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 22499536 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22513405 | CNVD |
Autism | 22958593 | CNVD |
Autism | 18184952 | CNVD |
Autism | 19966786 | CNVD |
Autism | 21394203 | CNVD |
Autism | 21969575 | CNVD |
Autism | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Autism | 20942916 | CNVD |
Epilepsy | 20970697 | CNVD |
Intellectual disability | 22045946 | CNVD |
Mental retardation | 19966786 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
Autism | 18923514 | CNVD |
Obesity | 21881559 | CNVD |
Obesity | 21956041 | CNVD |
Autism | 20659124 | CNVD |
Mental retardation | 21062444 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 22885689 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 20970697 | CNVD |
Schizophrenia | 20433910 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autism | 19242545 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Schizophrenia | 21399695 | CNVD |
Autism | 21956041 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Autism | 22067053 | CNVD |
Autism | 18156158 | CNVD |
Mental retardation | 20152051 | CNVD |
Autism | 19218893 | CNVD |
Autism | 21289514 | CNVD |
Schizophrenia | 19855392 | CNVD |
neurodevelopmental Syndrome | 20503337 | CNVD |
Benign familial neonatal-infantile seizures | 21060786 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Cancer | 21183584 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 21045282 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Autism | 19050728 | CNVD |
Epilepsy | 20923578 | CNVD |
Psychiatric disorder | 19050728 | CNVD |
Schizophrenia | 19348701 | CNVD |
Attention deficit hyperactivity disorder | 19097825 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19955444 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 19571808 | CNVD |
Breast cancer | 20409316 | CNVD |
Severe combined immunodeficiency | 19097825 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Autism | 18522746 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 19287141 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 20967226 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22297974 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioma | 20126413 | CNVD |
Osteosarcoma | 21215367 | CNVD |
Autism | 21865298 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:32002400-32002800 | Enhancers | HepG2 | liver |
2 | chr16:32051200-32051600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr16:32051400-32051600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr16:32051400-32051600 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr16:32077600-32078000 | Enhancers | Dnd41 | blood |
6 | chr16:32095200-32095400 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr16:32095400-32096400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr16:32096000-32096200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
9 | chr16:32096000-32096200 | Active TSS | Primary T regulatory cells fromperipheralblood | blood |
10 | chr16:32096200-32096400 | Flanking Bivalent TSS/Enh | Primary B cells from peripheral blood | blood |
11 | chr16:32096200-32096400 | Flanking Bivalent TSS/Enh | Primary T regulatory cells fromperipheralblood | blood |
12 | chr16:32096200-32096400 | Flanking Bivalent TSS/Enh | Fetal Adrenal Gland | Adrenal Gland |
13 | chr16:32096200-32096600 | Flanking Bivalent TSS/Enh | Placenta | Placenta |
14 | chr16:32096200-32096800 | Active TSS | Primary T helper cells fromperipheralblood | blood |
15 | chr16:32096200-32096800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr16:32096200-32097000 | Bivalent/Poised TSS | Primary T helper cells PMA-I stimulated | -- |
17 | chr16:32096200-32097200 | Active TSS | Primary T cells from cord blood | blood |
18 | chr16:32096200-32097200 | Flanking Bivalent TSS/Enh | Primary T cells fromperipheralblood | blood |
19 | chr16:32096200-32097200 | Active TSS | Primary T helper naive cells fromperipheralblood | blood |
20 | chr16:32096200-32097200 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
21 | chr16:32096200-32097200 | Active TSS | Primary mononuclear cells fromperipheralblood | Blood |
22 | chr16:32096200-32097400 | Active TSS | Primary T cells effector/memory enriched fromperipheralblood | blood |
23 | chr16:32096200-32097400 | Active TSS | Right Atrium | heart |
24 | chr16:32096200-32097400 | Bivalent/Poised TSS | A549 | lung |
25 | chr16:32096200-32097400 | Active TSS | Osteobl | bone |
26 | chr16:32096400-32096600 | Flanking Bivalent TSS/Enh | Primary monocytes fromperipheralblood | blood |
27 | chr16:32096400-32096600 | Flanking Bivalent TSS/Enh | Primary Natural Killer cells fromperipheralblood | blood |
28 | chr16:32096400-32096600 | Bivalent/Poised TSS | Duodenum Smooth Muscle | Duodenum |
29 | chr16:32096400-32096800 | Bivalent/Poised TSS | Primary B cells from peripheral blood | blood |
30 | chr16:32096400-32096800 | ZNF genes & repeats | Primary hematopoietic stem cells short term culture | blood |
31 | chr16:32096400-32096800 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
32 | chr16:32096400-32096800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
33 | chr16:32096400-32096800 | ZNF genes & repeats | Right Ventricle | heart |
34 | chr16:32096400-32096800 | Active TSS | HSMM | muscle |
35 | chr16:32096400-32097000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
36 | chr16:32096400-32097200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
37 | chr16:32096400-32097200 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
38 | chr16:32096400-32097200 | Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
39 | chr16:32096400-32097200 | Active TSS | Rectal Smooth Muscle | rectum |
40 | chr16:32096400-32097400 | Bivalent/Poised TSS | Primary T regulatory cells fromperipheralblood | blood |
41 | chr16:32096400-32097600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
42 | chr16:32096600-32096800 | Bivalent Enhancer | Placenta | Placenta |
43 | chr16:32096600-32097000 | Bivalent/Poised TSS | Primary monocytes fromperipheralblood | blood |
44 | chr16:32096600-32097000 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
45 | chr16:32096600-32097200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
46 | chr16:32096800-32097000 | Flanking Bivalent TSS/Enh | Primary T helper cells fromperipheralblood | blood |
47 | chr16:32096800-32097000 | Flanking Bivalent TSS/Enh | Foreskin Keratinocyte Primary Cells skin03 | Skin |
48 | chr16:32096800-32097000 | Bivalent Enhancer | Dnd41 | blood |
49 | chr16:32096800-32097200 | Flanking Bivalent TSS/Enh | Primary B cells from peripheral blood | blood |
50 | chr16:32096800-32097200 | Flanking Bivalent TSS/Enh | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |